No Results Found
Try adjusting your search to find what you’re looking for.
7/08/2026
NuCicer Introduces Nuchi, a New Class of High-Protein Chickpeas Designed for Clean-Label Food Formulation
NuCicer, a crop improvement & design company, announced Nuchi™ , a whole new class of high-protein chickpeas. Nuchi (“new + chickpea”) is the product of foundational plant genetics research accelerated by NuCicer's AI-driven genomic modeling and speed-breeding technology.
Read More
7/07/2026
Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research
Alamar Biosciences, (Nasdaq: ALMR), a leader in precision proteomics, launched the first commercial eMTBR-Tau immunoassay, now available in the NULISAseq™ Neuro 220 multiplexed panel kits, deployable on the entire installed base of ARGO™ HT instruments, and as a single-plex assay through the company’s Technology Access Program.
Read More
6/22/2026
Bayer and Iambic collaborate to advance AI drug discovery focused on small molecules using Iambic’s AI platform.
Bayer and Iambic Therapeutics Inc., a clinical-stage life science and technology company developing novel medicines using its AI-driven platform, today announced a drug discovery collaboration in which Bayer will discover new medicines using Iambic’s AI-driven platform. The collaboration is focused on small molecule discovery.
Read More
6/16/2026
Illumina Ventures Announces Winners of Inaugural Irish Genomics Business Plan Competition
University College Dublin’s NAX Bioscience and Trinity College Dublin’s Imragen recognised for novel genomics-driven
technologies and commercial potential
Read More